Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140013/S019

MINERVA ENDOMETRIAL ABLATION SYSTEM

Axora Medical, Inc. · Decision date Nov 5, 2026

MEDTECHLEDGER EXPLANATIONP140013/S019

What did the FDA decide?

The FDA recorded a 30-Day Notice decision, OK30, dated 2026-11-05 for P140013/S019, a supplement to the Minerva Endometrial Ablation System (product code MNB, obstetrics and gynecology) held by Axora Medical, Inc. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager or supplier.

The recorded statement covers elimination of duplicate final QC functional testing and 30-cycle burn-in that the PMA holder performed on Minerva RF Controllers, after equivalent testing was completed at Apical Instruments. This is a manufacturing and testing change to a component of the system, not a new approval of the whole device. The source does not describe the equivalence data, the controller's role in the procedure, or any clinical implications.

FDA approval order statement

elimination of the duplicate final QC functional testing and 30-cycle burn-in performed by the PMA holder on Minerva RF Controllers following completion of equivalent testing at Apical Instruments
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Obstetrics/Gynecology
Decision date
Nov 5, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140013/S019
Regulatory pathway
PMA supplement
Product code
MNB
Decision code
OK30
Decision date
Nov 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, thermal ablation, endometrial.

Product code
MNB
FDA device class
3

For the original device and its historical approval scope, see PMA P140013. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140013 · Original PMA

    MINERVA ENDOMETRIAL ABLATION SYSTEM

  2. P140013/S019 received

    Application receipt date recorded by FDA.

  3. P140013/S019 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P140013. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140013

Product / regulatory recordCompanyPathwayDecision dateSource
Axora Medical, Inc.PMA approvalJul 27, 2015FDA

Explore the linked device profile

Other records with product code MNB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Axora Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1 Independent Dr. Suite 2300, Jacksonville, FL, 32202

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records